期刊文献+

新癀片药效学及急性毒性实验 被引量:12

Expermental study on pharmacodynamics and acute toxicity of Xinhuang tablets
原文传递
导出
摘要 目的研究新癀片的镇痛抗炎作用,并观察新癀片的急性毒性试验。方法采用醋酸所致的小鼠扭体反应、热板法测定小鼠的痛阈,观察新癀片的镇痛作用;采用二甲苯致小鼠耳廓肿胀模型、醋酸致小鼠腹腔毛细血管通透性增加模型,观察新癀片的抗炎作用。结果新癀片能减少醋酸所致小鼠扭体次数,明显提高小鼠的痛阈;抑制二甲苯所致小鼠耳廓肿胀和醋酸所致小鼠腹腔毛细血管通透性增加,且无急性毒性反应。结论在本试验条件下,新癀片有显著的镇痛抗炎作用,临床应用具有安全性。 Objective To study the main pharmacodynamics of Xinhuang tablets,and to observe its acute toxicity. Methods The response of writhes induced by acetic acid and pain threshold of mice determined with hot-plate test were studied to observe the analgesic effects of Xinhuang tablets. Anti-inflammatory action was observed by the methods of auricle swelling induced by dimethylbenzene and capillary permeability increase induced by acetic acid in mice. Results Xinhuang tablets significantly reduced the times of writhes induced by acetic acid,increased mice 's pain threshold; and obviously inhibited dimethylbenzene-induced auricle swelling ,the analgesic permeability induced by acetic acid. Xinhuang tablets had no acute toxic reaction. Conclusions Xinhuang tablets has significant analgesic effects and notable effects of anti-inflammation ,and is safe for clinical use.
出处 《毒理学杂志》 CAS CSCD 北大核心 2010年第3期208-210,共3页 Journal of Toxicology
关键词 新癀片 镇痛 抗炎 毒性试验 Xinhuang tablets Analgesia Anti-inflammatory Toxicity
  • 相关文献

参考文献4

二级参考文献38

  • 1[1]Lichtenstein D, Syngal S, Wlfe MM. Non-steroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rherm,1995;38:1:5~18.
  • 2[2]Bjarnason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs. Lewis A: Non-steroidal Anti-Inflammatory Drugs, Mechanisms and Clinical Uses. New York: NY, Marcel Dekker, 1994;145~157.
  • 3[3]Marie R, Griffin, MD. Epidemiology of non-steroidal antiinflammatory drug-associated gastrointestinal injury. Am J Med.1998;104: 23~28.
  • 4[4]Fujiwara Y, Schmassman A, Arakawa T, et al. Indomethacin interferes with epidermal growth factor binding and proliferative response of KATO Ⅲ cells. Digestion, 1995;56:364~369.
  • 5[5]Henry D, Robertson J. Non-steroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.Gastroenterology. 1993; 104:1083~ 1091.
  • 6[6]Fries JF, Williams CA, Michel BA et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med, 1991 ;91:213 ~222.
  • 7[7]Gutthamm SP, García LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and the risk of hospitalization for upper gastrointestinal bleeding and perforation in saskatche wan: a nested case-control study. Pharmacoepidemiol Drug Safety. 1994;3:S63.
  • 8[8]Loeb DS, Talley NJ, Ahlquist DA, et al. Long-term non-steroidal anti-inflammatorydrug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology, 1992;102 :1899~1905.
  • 9[9]Langman MJS, Weil J, Wainwright P, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal antiinflammatory drugs. Lancet, 1994 ;34 3 :107 5-107 8
  • 10[10]Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications. am J Med, 1999;106:13~23.

共引文献100

同被引文献106

引证文献12

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部